XSpray Pharma AB (OSTO:XSPRAY) Other Operating Expense : kr20.91 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Other Operating Expense?

XSpray Pharma AB's Other Operating Expense for the three months ended in Dec. 2024 was kr10.37 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr20.91 Mil.

XSpray Pharma AB's quarterly Other Operating Expense increased from Jun. 2024 (kr0.27 Mil) to Sep. 2024 (kr9.21 Mil) and increased from Sep. 2024 (kr9.21 Mil) to Dec. 2024 (kr10.37 Mil).

XSpray Pharma AB's annual Other Operating Expense declined from Dec. 2022 (kr28.74 Mil) to Dec. 2023 (kr8.36 Mil) but then increased from Dec. 2023 (kr8.36 Mil) to Dec. 2024 (kr40.82 Mil).

XSpray Pharma AB Other Operating Expense Historical Data

The historical data trend for XSpray Pharma AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Other Operating Expense Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

28.74

8.36

40.82

XSpray Pharma AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															8.75	1.06	0.27	9.21	10.37

XSpray Pharma AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr20.91 Mil.

XSpray Pharma AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

0GHZ:UK 6XP:Germany

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and XS00Y.

XSpray Pharma AB Headlines

No Headlines